Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
NCT ID:
NCT06131112
Eligibility Criteria:
Inclusion Criteria:
* Age =\> 18 years
* Group A: 22 patients with clinically suspected cardiac sarcoidosis Group B: 22 patients with known cardiac sarcoidosis Group C: Up to 10 patients with clinically suspected or confirmed acute lymphocytic myocarditis Group D: 22 patients with NET without known inflammatory heart disease who have previously been scanned with 64Cu-DOTATATE PET/CT as part of their routine diagnostic work-up or follow-up (control group)
Exclusion Criteria:
* Severe obesity (weight \> 140 kg)
* Pregnancy (negative point-of-care urine/serum human chorion gonadotropin is required in all fertile women)
* Severe claustrophobia
* Known allergy to 64Cu-DOTATATE
* Clinically critical condition which makes PET/CT impossible
* Diabetes with insulin dependence
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06131112
Study Brief:
Protocol Section:
NCT06131112